指南与共识临床生化质量管理与危急值

IFCC CGM工作组提出CGM系统性能临床评估与接受标准指南

Clinical assessment and acceptance criteria for continuous glucose monitoring (CGM) system performance: A proposed guideline by the IFCC Working Group on CGM.
指南 / 共识 · Clin Chim Acta · 2025-11-16

连续血糖监测(CGM)系统是现代糖尿病管理的重要工具,但其分析性能评估缺乏标准化。国际临床化学与检验医学联合会(IFCC)CGM工作组制定综合指南,定义了研究设计与程序要求、对照测量特征、准确性最低要求及性能表征。

要点

  • 指南由IFCC CGM工作组制定,旨在标准化CGM系统性能的临床评估。
  • 指南规定了研究设计、对照测量特征、准确性最低要求和性能表征。
  • 标准化评估有助于CGM系统间比较及CGM指标作为研究结果的解读。

核心结论

  • IFCC CGM工作组制定了CGM系统临床评估与接受标准的综合指南。

研究设计与样本

  • 指南由国际临床化学与检验医学联合会(IFCC)CGM工作组制定。

关键数值与推荐

  • 指南定义了研究设计与程序的要求。
  • 指南定义了对照测量的特征要求。
  • 指南定义了准确性的最低要求。
  • 指南定义了性能表征的要求。

临床怎么用

  • 临床评估CGM系统性能时应遵循该指南的研究设计与程序要求。
  • 使用CGM指标作为研究结果时需考虑评估方法的标准化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Continuous glucose monitoring (CGM) systems are essential tools for modern diabetes care. However, the assessment of their analytical performance has been hindered by a lack of standardization. This poses challenges for the field, as the choice of study procedures and evaluation methods can influence the observed performance, further complicating the comparisons between CGM systems and confounding the interpretation and use of CGM metrics as research outcomes. To address this issue, the Working Group on CGM of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) has developed a comprehensive guideline for the clinical assessment of CGM systems. The guideline defines requirements for study design and procedures, characteristics of comparator measurements, minimum requirements for accuracy, and performance characterization.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Pleus S, Eichenlaub M, Dabla PK, et al. Clinical assessment and acceptance criteria for continuous glucose monitoring (CGM) system performance: A proposed guideline by the IFCC Working Group on CGM. Clin Chim Acta. 2025. PMID: 41253217. doi:10.1016/j.cca.2025.120728

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。